FDA Approves Frontline Immunotherapy for Gastric Cancers
The US Food and Drug Administration (FDA) today approved the immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) in conjunction with certain chemotherapies …
Home »
The US Food and Drug Administration (FDA) today approved the immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) in conjunction with certain chemotherapies …
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KANJINTI® Intravenous infusion Contains the active ingredient …